Cape Bio Pharms
Cape Town
About Cape Bio Pharms
Cape Bio Pharms is a biopharming company that uses its plant-based expression technology to produce a wide range of recombinant proteins for use in biomedical research, in rapid diagnostic test kits and potential vaccine and therapeutic applications. Plant expression technology offers superior economics and a production platform that is agile, flexible and capable of expressing complex molecular structures. It's also an ethical alternative as no animals are used in the making of its proteins.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $66.4M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2023)
- Website: capebiopharms.com
- Phone: 021 286 2835
Industries & Categories
Biopharma, Biotechnology, Environmental Engineering, Genetics, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/cape-bio-pharms-125515 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.